Human serum albumin immobilized on magnetizable beads: A rapid method for compound HSA binding study
Cody Thomas,Alexander Byer-Alcorace,Ting Wang
DOI: https://doi.org/10.1016/j.xphs.2024.01.018
IF: 3.8
2024-02-07
Journal of Pharmaceutical Sciences
Abstract:Immobilized human serum albumin (HSA) was developed by coupling His-tagged HSA onto Ni 2+ -coupled magnetizable beads (HSA-beads), allowing the HSA to be easily removed from incubation components. The HSA-beads system provides a rapid and convenient method to study HSA compound binding. In this study, the HSA-beads system was characterized and evaluated as a tool for assessing compound HSA binding properties. The free fraction (f u ) values of test compounds measured using HSA-beads were comparable to those determined by equilibrium dialysis (ED), which is commonly used to evaluate albumin binding in vitro. The equilibrium dissociation constant (K d ) values determined for a series of compounds using the HSA-beads method demonstrated good correlation with literature data. This good correlation also suggests that the binding of His-HSA to the beads does not impact the conformations of the two compound binding sites of HSA, as the range of compounds tested encompassed binding to both sites. Furthermore, the K d values of representative compounds itraconazole and BIRT2584 that were difficult to assess using ED, due to significant cellulose membrane adsorption, were successfully determined. The HSA-beads provide several advantages over ED, such as simple preparation, short assay incubation duration, and the ability to quantify both free and HSA-bound species of the test compound, facilitated by the simple separation of HSA-beads from the solution phase using a magnetic field. These properties render the HSA-beads method suitable for high-throughput studies on compound HSA binding.
pharmacology & pharmacy,chemistry, medicinal, multidisciplinary